Lumera Announces New Podcast Interview with Panos Lekkas

Lumera Corporation, a leader in the emerging field of nanotechnology, announced today the release of its newest podcast interview with Panos C. Lekkas, Founder and President of Xstream Technologies LLC.

Xstream Technologies LLC, an engineering firm in Boston, offers consulting services in areas of next-generation communications such as high-speed wireless, electro-optics and radar sensor systems. Lekkas, who is a global expert in wireless and wireless security, has been involved with Lumera in developing their millimeter wave wireless communication system and has been instrumental in certain design aspects of the system.

“Photonics devices will revolutionize the broadband wireless industry because of the high performance that’s becoming available with technologies like Lumera’s. This will help make the technology affordable and available to a wide audience,” said Lekkas in his podcast interview.

“We are pleased to be working with expert scientists such as Panos in developing our cutting-edge technologies, which we expect will significantly transform the future of the wireless industry,” commented Lumera Chief Executive Officer Tom Mino.

“Photonics is a revolutionary approach because it is counter-intuitive to people who are accustomed to [traditional] transmitters and receivers and it is faster than electronics,” said Lekkas in his podcast interview. “This technology is more reliable and will become less expensive as it matures. It is an exciting time for Lumera because the company will lead the market with the technologies that they are creating.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.